By Keith Goldberg ( June 26, 2012, 5:15 PM EDT) -- Covidien PLC didn't adequately respond to safety issues surrounding its tissue reinforcement system Duet TRS — which it voluntarily recalled in January after three patients died — and didn't comply with federal manufacturing requirements, according to a U.S. Food and Drug Administration warning letter released Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.